In addition to curcumin, berberine (BBR), a natural product and traditional Chinese medicine, can downregulate PD-L1 in non-small cell lung cancer (NSCLC) to strengthen the tumor-infiltrating T-cell-mediated immune response by reducing CSN5 activity [107, 109] (Table 1). The gene discussed is CD274; the disease is non-small cell lung carcinoma.